“Study of 18β glycyrrhetinic acid for the prevention of progression of diabetes induced neuropathy in laboratory animals”, Int. J. Pharm. Sci. Drug Res., vol. 13, no. 2, pp. 107–119, Mar. 2021, doi: 10.25004/IJPSDR.2021.130201.